Flavonoids and the brain: Evidences and putative mechanisms for a protective capacity

Current Neuropharmacology

Volumn 3, Issue 3, 2005, Pages 193-205

  Dajas, F ^a   Arredondo, F ^a   Echeverry, C ^a   Ferreira, M ^a   Morquio, A ^a   Rivera, F ^a  

^a INSTITUTO DE INVESTIGACIONES BIOLÓGICAS CLEMENTE ESTABLE   (Uruguay)

Author keywords

Antioxidants; Brain; Flavonoids; Ischemia; Oxidative stress

Indexed keywords

CALCIUM; CATECHIN; CRATAEGUS EXTRACT; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONOID; FLAVOPIRIDOL; FREE RADICAL; GENISTEIN; GINKGO BILOBA EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IRON; KAEMPFEROL; MYRICETIN; NARINGENIN; PHOSPHOTRANSFERASE; POLYPHENOL; QUERCETIN; RUTOSIDE; SILYMARIN; TANGERETIN; WOGONIN;

AGING; ALZHEIMER DISEASE; BEVERAGE; BRAIN DISEASE; CALCIUM HOMEOSTASIS; CEREBROVASCULAR DISEASE; CHINESE HERB; CLINICAL TRIAL; DATA ANALYSIS; DEMENTIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; IRON CHELATION; METABOLITE; MORBIDITY; MORTALITY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PLANT; RED WINE; REVIEW; SIGNAL TRANSDUCTION; STROKE; TEA; VEGETABLE; VEGETARIAN DIET;

EID: 22944475828     PISSN: 1570159X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570159054368303     Document Type: Review

References (151)

1. Abd El Mohsen, M.M., Kuhnle, G., Rechner, A.R., Schroeter, H., Rose, S., Jenner, P., Rice-Evans, C.A. (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic. Biol. Med., 33, 1693-1702.
2. Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C., Remesy, C., Chap, H., Payrastre, B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol., 53, 1649-1657.
3. Ahlemeyer, B., Krieglstein, J. (2003) Neuroprotective effects of Ginkgo biloba extract. Cell. Mol. Life Sci., 60, 1779-1792.
4. Altavilla, D., Crisafulli, A., Marini, H., Esposito, M., Dànna, R., Corrado, F., Bitto, S., Squadrito, F. (2004) Cardiovascular effects of the phytoestrogen genistein. Curr. Med. Chem. Cardiovasc. Hematol. Agents, 2, 179-186.
5. Ames, B.N., Shigenaga, M.K., Hagen, T.M. (1993) Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA, 90, 7915-7922.
6. Arredondo, M.F., Blasina, F., Echeverry, C., Morquio, A., Ferreira,M., Abin-Carriquiry, J. A., Lafon, L., Dajas, F. (2004) Cytoprotection by Achyrocline satureioides (Lam) D.C. and some of its main flavonoids against oxidative stress. J. Ethnopharmacol., 91, 13-20.
7. Arrigo, A.P. (1999) Gene expression and the thiol redox state. Free Radic. Biol. Med., 27, 936-944.
8. Aruoma, O.I., Bahorum, T., Jen, L. (2003) Neuroprotection by bioactive components in medicinal and food plant extracts. Mutat. Res., 544, 203-215.
9. Avila, M.A., Velasco, J.A., Cansado, J., Notario, V. (1994) Quercetin mediates the down-regulation of mutant p53 in the human breast cancer cell line MDA-MB468. Cancer Res., 54, 2424-2428.
10. Azuma, K., Ippoushi, K., Ito, H., Higashio, H., Terao, J. (2002) Combination of lipids and emulsifiers enhances the absorption of orally administered quercetin in rats. J. Agric. Food Chem., 50, 1706-1712.
11. Bae, H.J., Mun, K.C., Park, W.K., Lee, S.R., Suh, S.I., Baek, W.K., Yim, M.I., Kwon, T.K., Song, D.K. (2002)EGCG attenuates AMPA-induced intracellular calcium increase in hippocampal neurons. Biochem. Biophys. Res. Commun., 290, 1506-1512.
12. Bastianetto, S., Quiron, R. (2002) Natural extracts as possible protective agents of brain aging. Neurobiol. Aging, 23, 891-897.
13. Blaylock, RL.(1999)Neurodegeneration and Aging of the Central Nervous System: Prevention and Treatment by Phytochemicals and Metabolic Nutrients. Integr. Med., 1, 117-133.
14. Bokkenheuser, V. D., Shackleton, C. H. L., Winter, J. (1987) Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem. J., 248, 953-956.
15. Brusselmans, K., Vrolix, R., Verhoeven, G., Swinen, J.V. (2005) Induction of Cancer Cell Apoptosis by Flavonoids Is Associated with Their Ability to Inhibit Fatty Acid Synthase Activity. J. Biol. Chem., 280, 5636-5645.
16. Castelluccio, C., Paganga, G., Melikian, N., Bolwell, G., Pridham, J., Sampson, J., Rice-Evans, C. (1995) Antioxidant potential of intermediates in phenylpropanoid metabolism in higher plants. FEBS lett., 368, 188-192.
17. Chandrasekaran, K., Mehrabian, Z., Spinnewyn, B., Drieu, K., Fiskum, G. (2001) Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Brain Res., 922, 282-292.
18. Chen, L., Yang, X., Jiao, H., Zhao, B. (2004) Effect of tea catechins on the change of glutathione levels caused by Pb(++) in PC12 cells. Chem. Res. Toxicol., 17, 922-928.
19. Chen, M., Wang, Y., Liu, Y., Hou, X.Y., Zhang, Q.G., Meng, F.J., Zhang, G.Y. (2003) Possible mechanisms underlying the protective effects of SY-21, an extract of a traditional Chinese herb, on transient brain ischemia/reperfusion-induced neuronal death in rat hippocampus. Brain Res., 989, 180-186.
20. Choi, J.A., Kim, J.Y., Lee, J.Y., Kang, C.M., Kwon, H.J., Yoo, Y.D., Kim, T.W., Lee, Y.S., Lee, S.J. (2001) Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol., 19, 837-844.
21. Clark, W.M., Rinker, L.G., Lessov, N.S., Lowery, S.L., Cipolla, M.J. (2001) Efficacy of antioxidant therapies in transient focal ischemia in mice. Stroke, 32, 1000-1004.
22. Clemens, J.A., Panetta, J.A. (1994) Neuroprotection by antioxidants in models of global and focal ischemia. Ann. N. Y. Acad. Sci., 738, 250-256.
23. Cotelle, N., Bernier, J.L., Catteau, J.P., Pommery, J., Wallet, J.C., Gaydou, E.M. (1996) Antioxidant properties of hydroxy-flavones. Free Radic. Biol. Med., 20, 35-43.
24. Cushman, M., Nagarathnam, D., Burg, D.L., Geahlen, R.L. (1991) Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues. J. Med. Chem., 34, 798-806.
25. Da Luz, P.L., Coimbra, S.R. (2004) Wine, alcohol and atherosclerosis: clinical evidences and mechanisms. Braz. J. Med. Biol. Res., 37, 1275-1295.
26. Dajas, F., Rivera, F., Blasina, F., Arredondo, F., Echeverry, C., Lafon, L., Morquio, A., Heizen, H. (2003) Cell culture protection and in vivo neuroprotective capacity of flavonoids. Neurotox. Res., 5, 425-432.
27. Dalton, T.P., Chen, Y., Schneider, S.N., Nebert, D.W., Shertzer, H.G. (2004) Genetically altered mice to evaluate glutathione homeostasis in health and disease. Free Radic. Biol. Med., 37, 1511-1526.
28. Datla, K.P., Christidou, M., Widmer, W.W., Rooprai, H.K., Dexter, D.T. (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport, 12, 3871-3875.
29. De Smet, P.A. (2002) Herbal remedies. N. Engl. J. Med., 347, 2046-2056.
30. DeFeudis, F.V., Drieu, K. (2000) Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr. Drug Targets, 1, 25-58.
31. Dekermendjian, K., Kahnberg, P., Witt, M.R., Sterner, O., Nielsen, M., Liljefors, T. (1999) Structure-activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J. Med. Chem., 42, 4343-4350.
32. Donovan, J.L., Crespy, V., Manach, C., Morand, C., Besson, C., Scalbert, A., Remesy, C. (2001) Catechin is metabolized by both the small intestine and liver of rats. J. Nutr., 131, 1753-1757.
33. El-Sherbiny, D.A., Khalifa, A.E., Attia, A.S., Eldenshary Eel, D. (2003) Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Acta Neurochir. Suppl., 76, 525-533.
34. Fang, F., Han, Y.J., Cui, Z.Q. (2001) The protective effects of tea catechins on the injury of cerebral ischemia and reperfusion in rats. Zhongguo Zhong Yao Za Zhi, 26, 777-780.
35. Ferriola, P.C., Cody, V., Middleton, E. Jr. (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol., 38, 1617-1624.
36. Frankel, E.N., Kanner, J., German, J.B., Parks, E., Kinsella, J.E. (1993) Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet, 341, 454-457.
37. Fukagawa, N.K. (1999) Aging: is oxidative stress a marker or is it causal? Proc. Soc. Exp. Biol. Med., 222, 293-298.
38. Galati, G., Chan, T., Wu, B., O'Brien, P.J. (1999) Glutathione-dependent generation of reactive oxygen species by the peroxidase-catalyzed redox cycling of flavonoids. Chem. Res. Toxicol., 12, 521-525.
39. Gamet-Payrastre, L., Manenti, S., Gratacap, M.P., Tulliez, J., Chap, H., Payrastre, B. (1999) Flavonoids and the inhibition of PKC and PI 3-kinase. Gen. Pharmacol., 32, 279-286.
40. Geleijnse, J.M., Launer, L.J., Hofman, A., Pols, H.A., Witteman, J.C. (1999) Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch. Intern. Med., 159, 2170-2174.
41. Gertz, H.J., Kiefer, M. (2004) Review about Ginkgo biloba special extract EGb 761 (Ginkgo). Curr. Pharm. Des., 10, 261-264.
42. Gil, B., Sanz, M.J., Terencio, M.C., Ferrandiz, M.L., Bustos, G., Paya, M., Gunasegaran, R., Alcaraz, M.J. (1994) Effects of flavonoids on Naja naja and human recombinant synovial phospholipases A2 and inflammatory responses in mice. Life Sci., 54, PL333-338.
43. Gilgun-Sherki, Y., Rosenbaum, Z., Melamed, E., Offen, D. (2002) Antioxidant therapy in acute central nervous system injury: current state. Pharmacol. Rev., 54, 271-284.
44. Gohil, K. (2002) Genomic responses to herbal extracts: lessons from in vitro and in vivo studies with an extract of Ginkgo biloba. Biochem. Pharmacol., 64, 913-917.
45. Gorelick, P.B. (2002) Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke, 33, 862-875.
46. Griffiths, L.A., Barrow, A. (1972) Metabolism of flavonoid compounds in germ-free rats. Biochem. J., 130, 1161-1162.
47. Gupta, R., Singh, M., Sharma, A. (2003) Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacol. Res., 48, 209-215.
48. Haddad, J.J. (2002) Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal., 14, 879-897.
49. Haddad, J.J. (2004) Oxygen sensing and oxidant/redox-related pathways. Biochem. Biophys. Res. Commun., 316, 969-977.
50. Halliwell, B. (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet, 344, 721-724.
51. Halliwell, B., Murcia, M.A., Chirico, S., Aruoma, O.I. (1995) Free radicals and antioxidants in food and in vivo: what they do and how they work. Crit. Rev. Food Sci. Nutr., 35, 7-20.
52. Halliwell, B., Gutteridge, J.M.N. (1998) Antioxidant defences. En Free radicals in biology and Medicine. Oxford University Press, pp 105-245.
53. Harvey, A. (2000) Strategies for discovering drugs from previously unexplored natural products. Drug Disc. Today, 5, 294-300.
54. Heart Disease and Stroke Statistics-American Heart Association, 2004 Update.
55. Heo, H.J., Kim, D.O., Shin, S.C., Kim, M.J., Kim, B.G., Shin, D.H. (2004) Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection. J. Agric. Food Chem., 52, 1520-1525.
56. Herrmann, K. (1976) Flavonoids and flavones in food plants: a review. Food Technol., 11, 433-448.
57. Hertog, M.G., Feskens, E.J., Hollman, P.C., Katan, M.B., Kromhout, D. (1993) Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet, 342, 1007-1011.
58. Hollman, P.C., de Vries, J.H., van Leeuwen, S.D., Mengelers, M.J., Katan, M.B. (1995) Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr., 62, 1276-1282.
59. Hong, H., Liu, G.Q. (2004) Scutellarin attenuates oxidative glutamate toxicity in PC12 cells. Planta Med., 70, 427-431.
60. Hoult, J.R., Moroney, M.A., Paya, M. (1994) Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase. Meth. Enzymol., 234, 443-454.
61. Huang, Y.T., Hwang, J.J., Lee, P.P., Ke, F.C., Huang, J.H., Huang, C.J., Kandaswami, C., Middleton, E. Jr., Lee, M.T. (1999) Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol., 128, 999-1010.
62. Jenner, P. (1996) Oxidative stress in Parkinson's disease and other neurodegenerative disorders. Pathologie-Biologie, 44, 57-64.
63. Kim, S.R., Park, M.J., Lee, M.K., Sung, S.H., Park, E.J., Kim, J., Kim, S.Y., Oh, T.H., Markelonis, G.J., Kim, Y.C. (2002) Flavonoids of Inula britannica protect cultured cortical cells from necrotic cell death induced by glutamate. Free Radic. Biol. Med., 32, 596-604.
64. Kim, Y., Park, E.J., Kim, J., Kim, S.R., Kim, Y.Y. (2001) Neuroprotective constituents from Hedyotis diffusa. J. Nat. Prod., 64, 75-78.
65. Kobuchi, H., Roy, S., Sen, C.K., Nguyen, H.G., Packer, L. (1999) Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am. J. Physiol., 277, C403-411.
66. Kong, A.N., Yu, R., Chen, C., Mandlekar, S., Primiano, T. (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch. Pharm. Res., 23, 1-16.
67. Krishna, P., Christidou.M., Widmer, W., Harcharan, K., Rooprai, K., Dexter, D. (2001) Tissue distribution and neuroprotective effects of citrus flavonoids tangeretin in a rat model Parkinson's disease. Neuropharmacol. Neurotoxicol., 12, 3871-3875.
68. Kuhnle, G., Spencer, J.P., Schroeter, H., Shenoy, B., Debnam, E.S., Srai, S.K., Rice-Evans, C., Hahn, U. (2000) Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem. Biophys. Res. Commun., 277, 507-512.
69. Kurz, A., Van Baelen, B. (2004) Ginkgo biloba Compared with Cholinesterase Inhibitors in the Treatment of Dementia: A Review Based on Meta-Analyses by the Cochrane Collaboration. Dement. Geriatr. Cogn. Disord., 18, 217-226.
70. Laughton, M.J., Evans, P.J., Moroney, M.A., Hoult, J.R., Halliwell, B. (1991) Inhibition of mammalian 5-lipoxygenase and cyclooxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol., 42, 1673-1681.
71. Lee, E.J., Chen, H.Y., Wu, T.S., Chen, T.Y., Ayoub, I.A., Maynard, K.I. (2002) Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley rats. J. Neurosci. Res., 68, 636-645.
72. Lee, H., Bae, J.H., Lee, S.R. (2004) Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J. Neurosci. Res., 77, 892-900.
73. Lee, H., Kim, Y.O., Kim, H., Kim, S.Y., Noh, H.S., Kang, S.S., Cho, G.J., Choi, W.S., Suk, K. (2003) Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J, 17, 1943-1944.
74. Lee, H.H., Yang, L.L., Wang, C.C., Hu, S.Y., Chang, S.F., Lee, Y.H. (2003) Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death. Brain Res., 986, 103-113.
75. Lee, H.S., Kim, M.J. (2002) Selective responses of three Ginkgo biloba leaf-derived constituents on human intestinal bacteria. J. Agric. Food Chem., 50, 1840-1844.
76. Lee, S.F., Lin, J.K. (1997) Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr. Cancer, 28, 177-183.
77. Lee, S.Y., Kim, C.Y., Lee, J.J., Jung, J.G., Lee, S.R. (2003) Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain Res. Bulletin, 61, 399-406.
78. Leslie, E.M., Deeley, R.G., Cole, S.P. (2003) Bioflavonoid stimulation of glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). Drug Metab. Dispos., 31, 11-15.
79. Levites, Y., Amit, T., Youdim, M.B., Mandel, S. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem., 277, 30574-30580.
80. Linde, K., ter Riet, G., Hondras, M., Melchart, D., Willich, S.N. (2003) Characteristics and quality of systematic reviews of acupuncture, herbal medicines, and homeopathy. Forsch Komplementarmed Klass Naturheilkd, 10, 88-94.
81. Linford, N.J., Dorsa, D.M. (2002) 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids, 67, 1029-1040
82. Linford, N.J., Yang, Y., Cook, D.G., Dorsa, D.M. (2001) Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and p42/44 mitogen-activated protein kinase. J. Pharmacol. Exp. Ther., 299, 67-75.
83. Lissin, L.W., Oka, R., Lakshmi, S., Cooke, J.P. (2004) Isoflavones improve vascular reactivity in post-menopausal women with hypercholesterolemia. Vasc. Med., 9, 26-30.
84. Luo, Y. (2001) Ginkgo biloba neuroprotection: Therapeutic implications in Alzheimer's disease. J. Alzheimers Dis., 3, 401-407.
85. Manach, C., Scalbert, A., Morand, C., Remesy, C., Jimenez, L. (2004) Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 79, 727-747.
86. Mann, V.M., Cooper, J.M., Daniel, S.E., Srai, K., Jenner, P., Marsden, C.D., Schapira, A.H. (1994) Complex I, iron, and ferritin in Parkinson's disease substantia nigra. Ann. Neurol., 36, 876-881.
87. Matter, W.F., Brown, R.F., Vlahos, C.J. (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem. Biophys. Res. Commun., 186, 624-631.
88. Medina, J.H., Viola, H., Wolfman, C., Marder, M., Wasowski, C., Calvo, D., Paladini, A.C. (1997) Overview--flavonoids: a new family of benzodiazepine receptor ligands. Neurochem. Res., 22, 419-425.
89. Middleton, E. Jr., Kandaswami, C., Theoharides, T.C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 52, 673-751.
90. Modun, D., Music, I., Katalinic, V., Salamunic, I., Boban, M. (2003) Comparison of protective effects of catechin applied in vitro and in vivo on ischemia-reperfusion injury in the isolated rat hearts. Croat. Med. J., 44, 690-696.
91. Morquio, A., Rivera, F., Dajas, F. (2004) Photoprotection by topical application of Achyrocline satureioides ("marcela"). Phytochem. Res., (in press).
92. Myhrstad, M.C., Carlsen, H., Nordstrom, O., Blomhoff, R., Moskaug, J.O. (2002) Flavonoids increase the intracellular glutathione level by transactivation of the gamma-glutamylcysteine synthetase catalytical subunit promoter. Free Radic. Biol. Med., 32, 386-393.
93. Naidu, P.S., Kulkarni, S.K. (2004) Quercetin, a bioflavonoid, reverses haloperidol-induced catalepsy. Meth. Find Exp. Clin. Pharmacol., 26, 323-326.
94. Naidu, P.S., Singh, A., Kulkarni, S.K. (2004) Reversal of reserpine-induced orofacial dyskinesia and cognitive dysfunction by quercetin. Pharmacology, 70, 59-67.
95. Nicotera, P., Lipton, S.A. (1999) Excitotoxins in neuronal apoptosis and necrosis. J. Cereb. Blood Flow Metab., 19, 583-591.
96. Nijveldt, R.J., van Nood, E., van Hoorn, D.E., Boelens, P.G., van Norren, K., van Leeuwen, P.A. (2001) Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr., 74, 418-425.
97. Nobre Junior, H.V., Cunha, G.M., Maia, F.D., Oliveira, R.A., Moraes, M.O., Rao, V.S. (2003) Catechin attenuates 6-hydroxydopamine (6-OHDA)-induced cell death in primary cultures of mesencephallic cells. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol., 136, 175-180.
98. (+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia. Brain Res, 888, 138-149.
99. Orgogozo, J.M., Dartigues, J.F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., Breteler, M.B. (1997) Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev.Neurol,, 153, 185-192.
100. Pardridge, W.M. (2001) Neuroprotection in stroke: is it time to consider large-molecule drugs? Drug Disc. Today, 6, 751-753.
101. Ponto, L.L., Schultz, S.K. (2003) Ginkgo biloba extract: review of CNS effects. Ann.. Clin. Psychiatry, 15, 109-119.
102. Quintanilla, R.A., Orellana, D.I., Gonzalez-Billault, C., Maccioni, R.B. (2004) Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp. Cell Res., 295, 245-257.
103. Ratty, A.K., Sunamoto, J., Das, N.P. (1988) Interaction of flavonoids with 1,1-diphenyl-2-picrylhydrazyl free radical, liposomal membranes and soybean lipoxygenase-1. Biochem. Pharmacol., 37, 989-995.
104. Renaud, S., de Lorgeril, M. (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet, 339, 1523-1526.
105. Renaud, S., Ruf, J.C. (1994) The French paradox: vegetables or wine. Circulation, 90, 3118-3119.
106. Rice-Evans, C. (1995) Plant polyphenols: free radical scavengers or chain-breaking antioxidants? Biochem. Soc. Symp., 61, 103-116.
107. Rice-Evans, C. (2001) Flavonoid antioxidants. Curr. Med. Chem., 8, 797-807.
108. Rivera, F., Urbanavicius, J., Gervaz, E., Morquio, A., Dajas, F. (2004) Some aspects of the in vivo neuroprotective capacity of flavonoids: bioavailability and structure-activity relationship. Neurotox. Res., 6, 543-553.
109. Schafer, F.Q., Buettner, G.R. (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med., 30, 1191-1212.
110. Schmidley, J.W. (1990) Free radicals in central nervous system ischemia. Stroke, 21, 1086-1090.
111. Schroeter, H., Boyd, C., Spencer, J.P., Williams, R.J., Cadenas, E., Rice-Evans, C. (2002) MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol. Aging, 23, 861-880.
112. Schroeter, H., Spencer, J.P., Rice-Evans, C., Williams, R.J. (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem. J., 358, 547-557.
113. Selkoe, D.J. (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev., 81, 741-766.
114. Sharma, H.S., Drieu, K., Alm, P., Westman, J. (2000) Role of nitric oxide in blood-brain barrier permeability, brain edema and cell damage following hyperthermic brain injury. An experimental study using EGB-761 and Gingkolide B pretreatment in the rat. Acta Neurochir. Suppl., 76, 81-86.
115. Shutenko, Z., Henry, Y., Pinard, E., Seylaz, J., Potier, P., Berthet, F., Girard, P., Sercombe, R. (1999) Influence of the antioxidant quercetin in vivo on the level of nitric oxide determined by electron paramagnetic resonance in rat brain during global ischemia and reperfusion. Biochem. Pharmacol., 57, 199-208.
116. Sichel, G., Corsaro, C., Scalia, M., Di Bilio, A.J., Bonomo, R.P. (1991) In vitro scavenger activity of some flavonoids and melanins against O2-(.). Free Radic. Biol. Med., 11, 1-8.
117. Siesjo, B.K., Zhao, Q., Pahlmark, K., Siesjo, P., Katsura, K., Folbergrova, J. (1995) Glutamate, calcium, and free radicals as mediators of ischemic brain damage. Ann. Thorac. Surg., 59, 1316-1320.
118. Singh, A., Naidu, P.S., Gupta, S., Kulkarni, S.K. (2002) Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J. Med. Food, 5, 211-220.
119. Singh, A., Naidu, P.S., Kulkarni, S.K. (2003) Reversal of aging and chronic ethanol-induced cognitive dysfunction by quercetin a bioflavonoid. Free Radic. Res., 37, 1245-1252.
120. Smith, J.V., Burdick, A.J., Golik, P., Khan, I., Wallace, D., Luo, Y. (2002) Anti-apoptotic properties of Ginkgo biloba extract EGb 761 in differentiated PC12 cells. Cell. Mol. Biol., 48, 725-73.
121. Spencer, J. P., Rice-Evans, C., Williams, R. J. (2003) Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J. Biol.Chem., 278, 34783-34793.
122. Spencer, J.P., El Mohsen, M.M.A., Rice-Evans, C. (2004) Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch. Biochem. Biophys., 423, 148-161.
123. Spencer, J.P.E., Schroeter, H., Rechner, A.R., Rice Evans, C. (2001) Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid. Redox Signal., 3, 1023-1039.
124. Spencer, J.P.E., Schroeter, H., Shenoy, B., Krai, S.K., Debnam, E.S., Rice Evans, C. (2001) Epicatechin is the primary bioavailable form of the procyanidin dimers B2 and B5 after transfer across the small intestine. Biochem. Biophys. Res. Commun., 285, 588-593.
125. Suganuma, M., Okabe, S., Oniyama, M., Tada, Y., Ito, H., Fujiki, H. (1998) Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis, 19, 1771-1776.
126. Sun, A., Simonyi, A., Sun, G. (2002) The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med., 32, 314-318.
127. Suzuki, M., Tabuchi, M., Ikeda, M., Umegaki, K., Tomita, T. (2004) Protective effects of green tea catechins on cerebral ischemic damage. Medical Science Monitor: International Medical J. Exp. Clin. Res., 10, 166-174.
128. Takizawa, S., Fukuyama, N., Hirabayashi, H., Kohara, S., Kazahari, S., Shinohara, Y., Nakazawa, H. (2003) Quercetin, a natural flavonoid, attenuates vacuolar formation in the optic tract in rat chronic cerebral hypoperfusion model. Brain Res., 980, 156-160.
129. Teissedre, P. L., Frankel, E. N., Waterhouse, A. L., Peleg, H., German, J. B. (1996) Inhibition of in vitro human LDL oxidation by phenolic antioxidants from grapes and wines. J. Sci. Food Agric., 70, 55-61.
130. Teufel-Mayer, R., Gleitz, J., (1997) Effects of long-term administration of hypericum extracts on the affinity and density of the central serotonergic 5-HT1 A and 5-HT2 A receptors. Pharmacopsychiatry, 30, 113-116.
131. Touyz, R.M., Yao, G., Viel, E., Amiri, F., Schiffrin, E. (2004) Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J. Hyperten., 22, 1141-1149.
132. Townsend, D.M., Tew, K.D., Tapiero, H. (2003) The importance of glutathione in human disease. Biomed. Pharmacother., 57, 145-155.
133. Tribble, D.L. (2001) Antioxidants and atherosclerotic cardiovascular disease: unresolved issues. Coron. Artery Dis., 12 541-546.
134. Trieu, V.N., Dong, Y., Zheng, Y., Uckun, F.M. (1999) In vivo antioxidant activity of genistein in a murine model of singlet oxygen-induced cerebral stroke. Radiat. Res., 152, 508-516.
135. Van der Woude, H., Gliszczynska-Swiglo, A., Struijs, K., Smeets, A., Alink, G.M., Rietjens, I. (2003) Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett., 200, 41-47.
136. Van Dongen, M., van Rosssum, E., Kessels, A., Sielhorst, H., Knij, P. (2003) Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. J. Clin. Epidemiol., 56, 367-376.
137. Verdaguer, E., Jiménez, A., Canudas, A.M., Jorda, E., Sureda, F.J., Pallas, M., Camins, A. (2004) Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment. J. Pharmacol. Exp. Therap., 308, 609-616.
138. Walgren, R. A., Karnaky, K. J.Jr., Lindenmayer, G. E., Walle, T. (2000) Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J. Pharmacol. Exp. Therap, 294, 830-836.
139. Walgren, R. A., Lin, J.-T., Kinne, R. K.-H., Walle, T. (2000) Cellular uptake of dietary flavonoid quercetin 4′-beta-glucoside by sodium-dependent glucose transporter SGLT1. J. Pharmacol. Exp. Therap., 294, 837-843.
140. Wang, M. J., Lin, W. W, Chen, L.H., Chang, Y.H., Ou, H.C., Kuo, J.S., Hong, J.S., Jeng, K.C.G. (2002) Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur. J. Neurosci., 16, 2103-2112.
141. Willett, W.C. (1995) Diet, nutrition, and avoidable cancer. Environ. Health Perspect., 103, 165-170.
142. Williams, A.J., Dave, J.R., Phillips, J.B., Lin, Y., Mccaber, T., Tortella, F.C. (2000) Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G: in vitro (primary cerebellar neurons) and in vivo (rat model of transient focal brain ischemia) studies. J. Pharmacol. Exp. Therap., 294, 378-386.
143. Williams, J. R., Spencer, J. P. E., Rice-Evans, C. (2004) Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med., 36, 838-849.
144. Wolffram, S., Block, M., Ader, P. (2002) Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J. Nutr., 132, 630-635.
145. Wolfman, C., Viola, H., Paladini, A., Dajas, F., Medina, J.H. (1994) Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol. Biochem. Behav., 47, 1-4.
146. Wu, B. Y., Hoiyu, A. C. (2000) Quercetin inhibits c-fos, heat shock protein, and glial fibrillary acidic protein expression in injured astrocytes. J. Neurosci. Res., 62, 730-736.
147. Yanez, J., Vicente, V., Alcaraz, M., Castillo, J., Benavente-Garcia, O., Cano, M., Teruel, J.A. (2004) Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr. Cancer, 49, 191-199.
148. Yao, Y., Chinnici, C., Tang, H., Trojanowski, J.Q., Lee, V.M., Pratico, D. (2004) Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis. J. Neuroinflammation, 1, 21.
149. Yoshikawa, T., Naito, Y., Kondo, M. (1999) Ginkgo biloba leaf extract: review of biological actions and clinical applications. Antioxid. Redox Signal., 1, 469-480.
150. Youdim, K.A., Shukitt-Hale, B., Joseph, J.A. (2004) Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med., 37, 1683-1693.
151. Zava D.T., Duwe, G. (1997) Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr. Cancer, 27, 31-40.